HMCIB SPAC (Korea) Performance
| 226340 Stock | KRW 1,374 25.00 1.85% |
The company owns a Beta (Systematic Risk) of 0.24, which attests to not very significant fluctuations relative to the market. As returns on the market increase, HMCIB SPAC's returns are expected to increase less than the market. However, during the bear market, the loss of holding HMCIB SPAC is expected to be smaller as well. At this point, HMCIB SPAC 3 has a negative expected return of -0.43%. Please make sure to check out HMCIB SPAC's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if HMCIB SPAC 3 performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days HMCIB SPAC 3 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -8.7 B |
HMCIB |
HMCIB SPAC Relative Risk vs. Return Landscape
If you would invest 182,900 in HMCIB SPAC 3 on September 15, 2024 and sell it today you would lose (45,500) from holding HMCIB SPAC 3 or give up 24.88% of portfolio value over 90 days. HMCIB SPAC 3 is generating negative expected returns and assumes 3.1563% volatility on return distribution over the 90 days horizon. Simply put, 28% of stocks are less volatile than HMCIB, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
HMCIB SPAC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HMCIB SPAC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HMCIB SPAC 3, and traders can use it to determine the average amount a HMCIB SPAC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1352
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 226340 |
Estimated Market Risk
| 3.16 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average HMCIB SPAC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HMCIB SPAC by adding HMCIB SPAC to a well-diversified portfolio.
HMCIB SPAC Fundamentals Growth
HMCIB Stock prices reflect investors' perceptions of the future prospects and financial health of HMCIB SPAC, and HMCIB SPAC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HMCIB Stock performance.
| Return On Equity | 9.17 | |||
| Return On Asset | 0.0109 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 106.93 B | |||
| Shares Outstanding | 30.1 M | |||
| Price To Sales | 1.56 X | |||
| Revenue | 53.81 B | |||
| EBITDA | 1.74 B | |||
| Cash And Equivalents | 9.74 B | |||
| Cash Per Share | 992.31 X | |||
| Total Debt | 18.27 B | |||
| Debt To Equity | 0.38 % | |||
| Cash Flow From Operations | (24.89 B) | |||
| Total Asset | 83.55 B | |||
About HMCIB SPAC Performance
By analyzing HMCIB SPAC's fundamental ratios, stakeholders can gain valuable insights into HMCIB SPAC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HMCIB SPAC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HMCIB SPAC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bonne Co., Ltd. develops and supplies cosmetics in South Korea. Bonne Co., Ltd. was founded in 2009 and is based in Seoul, South Korea. Bonne is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about HMCIB SPAC 3 performance evaluation
Checking the ongoing alerts about HMCIB SPAC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HMCIB SPAC 3 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HMCIB SPAC 3 generated a negative expected return over the last 90 days | |
| HMCIB SPAC 3 has high historical volatility and very poor performance | |
| The company reported the revenue of 53.81 B. Net Loss for the year was (3.96 B) with profit before overhead, payroll, taxes, and interest of 14.44 B. | |
| HMCIB SPAC 3 has accumulated about 9.74 B in cash with (24.89 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 992.31. | |
| Roughly 54.0% of the company shares are owned by insiders or employees |
- Analyzing HMCIB SPAC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HMCIB SPAC's stock is overvalued or undervalued compared to its peers.
- Examining HMCIB SPAC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HMCIB SPAC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HMCIB SPAC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HMCIB SPAC's stock. These opinions can provide insight into HMCIB SPAC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HMCIB Stock analysis
When running HMCIB SPAC's price analysis, check to measure HMCIB SPAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HMCIB SPAC is operating at the current time. Most of HMCIB SPAC's value examination focuses on studying past and present price action to predict the probability of HMCIB SPAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HMCIB SPAC's price. Additionally, you may evaluate how the addition of HMCIB SPAC to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |